{
  "docId": "019de073-f021-770f-8b07-e7c119465e03",
  "docSlug": "6227ea40012eb82f352898e4936ae469",
  "documentTitle": "Bausch Health Companies | Results Presentation Deck | 48 slides",
  "authorId": "bausch-health-companies",
  "authorName": "Bausch Health",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.2938006,
  "pageNumber": 10,
  "pageCount": 48,
  "prevPage": 9,
  "nextPage": 11,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "balanced",
  "nDataPoints": 28,
  "notes": "Includes non-GAAP measures and specific segment performance drivers.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-f021-770f-8b07-e7c119465e03/10",
  "deckHref": "/decks/019de073-f021-770f-8b07-e7c119465e03",
  "deckJsonHref": "/decks/019de073-f021-770f-8b07-e7c119465e03.json",
  "deckAnchorHref": "/decks/019de073-f021-770f-8b07-e7c119465e03#slide-10",
  "components": [
    {
      "bbox": {
        "h": 0.25,
        "w": 0.9,
        "x": 0.05,
        "y": 0.22
      },
      "kind": "chart",
      "text": "Revenue mix by segment",
      "attrs": null,
      "subkind": "donut",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "695baaa5-52c4-4d8b-96f1-92ba2e82a262",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.05,
        "y": 0.88
      },
      "kind": "disclaimer",
      "text": "1. This is a non-GAAP measure or non-GAAP ratio. See Slide 3 and Non-GAAP Appendix for further information on non-GAAP measures and ratios. 2. Solta Medical sales mix during 2Q22 was 65% Consumables and 35% Console.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "91494b27-2a11-4644-ae1a-bc46504fe471",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.9,
        "x": 0.05,
        "y": 0.65
      },
      "kind": "list",
      "text": "Key drivers for revenue change",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ffe29164-70ae-4454-98cb-1001297c45cf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.45,
        "x": 0.04,
        "y": 0.07
      },
      "kind": "title",
      "text": "3Q22 Bausch Pharma + Solta revenue",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0e8f4ac0-0e9c-437b-9915-9c0af46e7632",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Chart Selection Guide",
      "slug": "chart-selection-guide",
      "agent": "Designer",
      "layer": "slide",
      "matchId": "1a7d29c4-544d-4cab-b2fd-75b5695a3497",
      "evidence": "chart/donut: Revenue mix by segment",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 20,
      "from": 9,
      "beatId": "affbaca2-b0eb-4a5e-88e5-eb067f6eec9e",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Satisfaction",
      "beatSlug": "monroes-sequence-satisfaction",
      "evidence": "The document presents financial results and guidance to demonstrate progress and satisfaction.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 24,
      "from": 5,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "05a42e5d-33da-405b-8ece-2b28299f64ad",
      "evidence": "The document implies that not taking action would result in missed opportunities and decreased financial performance.",
      "position": 0,
      "objective": "To highlight the cost of inaction and the benefits of the company's strategy",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}